These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function. Leroy A; Humbert G; Fillastre JP Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis. Francke EL; Appel GB; Neu HC Antimicrob Agents Chemother; 1979 Dec; 16(6):788-91. PubMed ID: 533260 [TBL] [Abstract][Full Text] [Related]
6. Intravenous azlocillin kinetics in patients on long-term hemodialysis. Aletta JM; Francke EF; Neu HC Clin Pharmacol Ther; 1980 Apr; 27(4):563-6. PubMed ID: 7357815 [TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacokinetics of azlocillin]. Singlas E; Haegel C Presse Med; 1984 Mar; 13(13):788-96. PubMed ID: 6231596 [TBL] [Abstract][Full Text] [Related]
8. Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency. Bergan T J Antimicrob Chemother; 1983 May; 11 Suppl B():101-14. PubMed ID: 6352598 [TBL] [Abstract][Full Text] [Related]
9. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function. Frimodt-Möller N; Maigaard S; Toothaker RD; Bundtzen RW; Brodey MV; Craig WA; Welling PG; Madsen PO Antimicrob Agents Chemother; 1980 Apr; 17(4):599-607. PubMed ID: 6446877 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of netilmicin in the presence of normal or impaired renal function. Humbert G; Leroy A; Fillastre JP; Oksenhendler G Antimicrob Agents Chemother; 1978 Jul; 14(1):40-4. PubMed ID: 686708 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function. Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of azlocillin in persons with normal and impaired renal functions. Fiegel P; Becker K Antimicrob Agents Chemother; 1978 Sep; 14(3):288-91. PubMed ID: 708008 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of habekacin in patients with renal insufficiency. Fillastre JP; Leroy A; Humbert G; Moulin B; Bernadet P; Josse S Antimicrob Agents Chemother; 1987 Apr; 31(4):575-7. PubMed ID: 3606062 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis. Giron JA; Meyers BR; Hirschman SZ; Srulevitch E Antimicrob Agents Chemother; 1981 Feb; 19(2):279-83. PubMed ID: 6214987 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of azlocillin in children with cystic fibrosis. Bergan T; Michalsen H Arzneimittelforschung; 1979; 29(12a):1955-7. PubMed ID: 543899 [TBL] [Abstract][Full Text] [Related]
17. Azlocillin treatment of urinary tract infection in patients on haemodialysis. Hallan H; Svarva PL; Svartås TM; Widerøe T Scand J Infect Dis Suppl; 1981; 29():55-8. PubMed ID: 6947406 [TBL] [Abstract][Full Text] [Related]
18. Piperacillin pharmacokinetics in subjects with chronic renal failure. Thompson MI; Russo ME; Matsen JM; Atkin-Thor E Antimicrob Agents Chemother; 1981 Mar; 19(3):450-3. PubMed ID: 6454382 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis. Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427 [TBL] [Abstract][Full Text] [Related]